Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Finger

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Nature Cell Biology|September 20, 2016
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrowRachelle W Johnson, Elizabeth C Finger, Monica M Olcina, et al.
Archives of General Psychiatry|May 7, 2008
Abnormal ventromedial prefrontal cortex function in children with psychopathic traits during reversal learningElizabeth C Finger, Abigail A Marsh, Derek G Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2011
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migrationOlga V Razorenova, Elizabeth C Finger, Renata Colavitti, et al.
Neurology|December 16, 2014
Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerabilityElizabeth C Finger, Julia MacKinley, Mervin Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2014
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and METErinn B Rankin, Katherine C Fuh, Laura Castellini, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
Neurology|March 6, 2021
Value-Generating Exploratory Trials in Neurodegenerative DementiasLauren G Friedman, Nicholas McKeehan, Yuko Hara, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Nature Cell Biology|September 20, 2016
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrowRachelle W Johnson, Elizabeth C Finger, Monica M Olcina, et al.
Archives of General Psychiatry|May 7, 2008
Abnormal ventromedial prefrontal cortex function in children with psychopathic traits during reversal learningElizabeth C Finger, Abigail A Marsh, Derek G Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2011
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migrationOlga V Razorenova, Elizabeth C Finger, Renata Colavitti, et al.
Neurology|December 16, 2014
Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerabilityElizabeth C Finger, Julia MacKinley, Mervin Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2014
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and METErinn B Rankin, Katherine C Fuh, Laura Castellini, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
Neurology|March 6, 2021
Value-Generating Exploratory Trials in Neurodegenerative DementiasLauren G Friedman, Nicholas McKeehan, Yuko Hara, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Pageof 6